Resources from the same session
The importance of myeloid cells in the TME
Presenter: Lisa Butterfield
Session: Joint ESMO-SITC Immunotherapy Primer
Resources:
Webcast
TIL-based therapy
Presenter: George Coukos
Session: Joint ESMO-SITC Immunotherapy Primer
Resources:
Webcast
Q&A
Presenter: Tullia Bruno
Session: Joint ESMO-SITC Immunotherapy Primer
Resources:
Webcast
Utilizing oncolytic virus as a new treatment modality
Presenter: Ramon Alemany
Session: Joint ESMO-SITC Immunotherapy Primer
Resources:
Webcast
Q&A
Presenter: Tullia Bruno
Session: Joint ESMO-SITC Immunotherapy Primer
Resources:
Webcast
The utility of radiographic imaging and radiotherapy in immunotherapy
Presenter: Ravi Patel
Session: Joint ESMO-SITC Immunotherapy Primer
Resources:
Webcast
Q&A
Presenter: Tullia Bruno
Session: Joint ESMO-SITC Immunotherapy Primer
Resources:
Webcast
Stromal cells in the TME
Presenter: Lan Gardner Coffman
Session: Joint ESMO-SITC Immunotherapy Primer
Resources:
Webcast
Q&A
Presenter: Tullia Bruno
Session: Joint ESMO-SITC Immunotherapy Primer
Resources:
Webcast
The microbiome influence on the TME
Presenter: Laurence Zitvogel
Session: Joint ESMO-SITC Immunotherapy Primer
Resources:
Webcast